Evidence map›Paper›PMID 42594417›Full record

ArticleThe journal of prevention of Alzheimer's disease2026

From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network.

Giovanna Zamboni, Manuela Tondelli, Giulia Vinceti, Chiara Gallingani, Zeno Bercini, Aurora Barbieri, Chiara Carbone, Najara Iacovino, Silvia Cossutti, Daniela Ballotta and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of prevention of Alzheimer's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Giovanna ZamboniDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy; Neurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy.
Manuela TondelliDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy; Neurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy. Electronic address: manuela.tondelli@unimore.it.
Giulia VincetiNeurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy.
Chiara GallinganiDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy; Neurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy.
Zeno BerciniDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy; Neurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy.
Aurora BarbieriDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy; Neurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy.
Chiara CarboneDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy.
Najara IacovinoDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy.
Silvia CossuttiDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy.
Daniela BallottaDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy.
Simone SalemmeDepartment of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, via Campi 287, 41122 Modena, Italy; International School of Advanced Studies, University of Camerino, Piazza Cavour 19/f, 62032, Camerino, Italy.
Annalisa ChiariNeurology Unit, Azienda Ospedaliero-Universitaria di Modena, Via Pietro Giardini 1355, 41126 Modena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer's diseaseanti-amyloid monoclonal antibodiesappropriate use recommendationsreal-world eligibility

Identifiers

PMID42594417
PMCPMC13499131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.